Pediatrix Medical Group, Inc. key statistics and ratios

In fiscal 2025, Pediatrix Medical Group, Inc. had return on equity of 20.3%, an operating margin of 10.9%, debt equal to 69.3% of equity and a current ratio of 1.66. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Pediatrix Medical Group, Inc.: financial ratios, annual
Fiscal year	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMSept 2026
Operating margin	18.0%	14.0%	14.4%	9.7%	5.7%	10.6%	8.8%	0.4%	−3.4%	10.9%	10.9%
Net margin	10.2%	9.8%	15.6%	−84.2%	−45.9%	6.9%	3.4%	−3.0%	−4.9%	8.6%	7.7%
Free-cash-flow margin	12.7%	14.9%	17.2%	19.0%	10.1%	2.3%	7.0%	5.2%	9.2%	13.2%	10.7%
Return on equity	11.8%	11.0%	8.7%	−65.3%	−70.9%	15.9%	7.4%	−6.9%	−12.3%	20.3%	17.5%
Return on assets	6.1%	5.7%	4.6%	−29.7%	−21.3%	4.3%	2.6%	−2.6%	−4.5%	7.5%	6.8%
Asset turnover	0.60	0.58	0.29	0.35	0.46	0.63	0.78	0.87	0.92	0.87	0.89
Current ratio	1.31	1.18	1.31	1.35	3.49	1.97	1.00	1.24	1.47	1.66	1.28
Debt to equity	62.1%	60.7%	64.4%	116.7%	234.1%	111.5%	72.6%	74.6%	80.7%	69.3%	68.0%
Interest cover (operating income ÷ interest)	9.1x	6.1x	2.7x	1.4x	0.9x	3.0x	4.4x	0.2x	n/m	5.8x	6.4x
Effective tax rate	36.8%	20.8%	26.9%	28.2%	—	20.1%	23.1%	—	—	23.6%	26.2%
Capital spending as % of revenue	1.2%	0.8%	1.0%	1.1%	1.7%	1.7%	1.5%	1.7%	1.1%	1.0%	0.9%
Free cash flow ÷ net income	124.5%	151.5%	110.4%	—	—	34.0%	206.9%	—	—	152.8%	139.6%
Dividends and buybacks ÷ free cash flow	15.3%	14.5%	101.9%	42.9%	4.8%	10.6%	64.5%	0.9%	0.9%	34.3%	100.8%

US$ thousands unless shown otherwise. Fiscal quarters.

Pediatrix Medical Group, Inc.: financial ratios, quarterly
Quarter	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026	2026 Q3Sept 2026
Operating margin	7.8%	7.0%	12.8%	13.8%	9.9%	8.7%	11.7%	13.0%
Net margin	6.1%	4.5%	8.4%	14.5%	6.8%	6.2%	8.2%	9.4%
Free-cash-flow margin	25.8%	−26.4%	28.3%	26.8%	22.0%	−28.6%	25.4%	22.5%
Current ratio	1.47	1.81	1.80	1.83	1.66	1.33	1.32	1.28
Debt to equity	79.9%	74.8%	70.0%	64.8%	65.9%	45.3%	45.2%	46.8%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

4 of 7 checks passed · September 30, 2026

What it owns · $2.1bn

Short-term assets $684mLonger-term assets $1.5bn

What it owes, and who funded it · $2.1bn

Short-term liabilities $536mLonger-term liabilities $754mShareholders' equity $850m

Short-term assets cover short-term liabilities $684m of assets due within a year against $536m of liabilities due within a year.
Short-term assets cover long-term liabilities $684m short-term assets against $754m of longer-dated liabilities.
More cash than debt $312m of cash against $398m of debt.
Debt below 40% of shareholders' equity Debt is 47% of equity.
Debt burden no higher than five years ago Debt to equity moved from 113% to 47% over five years.
A year's operating cash flow covers at least 20% of debt $227m of operating cash flow against $398m of debt.
Operating profit covers interest at least five times over Operating income of $213m against $33m of interest.

From Pediatrix Medical Group, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

47 /100

Moderate moat

How hard Pediatrix Medical Group's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

Returns on capital 4 / 20

Net income has been a median 3.8% of total assets over 10 years.
Durability 2 / 20

Operating margin has been a median 10.4%; its worst year was -10.9%.
Cash conversion 14 / 20

Free cash flow was positive in 8 of 9 years, at a median 9.7% of revenue.
Discipline 18 / 20

The diluted share count fell 3.9% over five years; stock-based pay has been a median 1.0% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: EHC vs MD ARDT vs MD CYH vs MD

More: Hospitals stocks compared, Health Care sector, rankings of US companies

Figures from Pediatrix Medical Group, Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pediatrix Medical Group, Inc.